These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32368563)

  • 1. Expression and Retention of Thymidine Phosphorylase in Cultured Reticulocytes as a Novel Treatment for MNGIE.
    Meinders M; Shoemark D; Dobbe JGG; Streekstra GJ; Frayne J; Toye AM
    Mol Ther Methods Clin Dev; 2020 Jun; 17():822-830. PubMed ID: 32368563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and Efficacy of Erythrocyte Encapsulated Thymidine Phosphorylase in Mitochondrial Neurogastrointestinal Encephalomyopathy.
    Levene M; Bain MD; Moran NF; Nirmalananthan N; Poulton J; Scarpelli M; Filosto M; Mandel H; MacKinnon AD; Fairbanks L; Pacitti D; Bax BE
    J Clin Med; 2019 Apr; 8(4):. PubMed ID: 30959750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial Neurogastrointestinal Encephalomyopathy Caused by Thymidine Phosphorylase Enzyme Deficiency: From Pathogenesis to Emerging Therapeutic Options.
    Yadak R; Sillevis Smitt P; van Gisbergen MW; van Til NP; de Coo IF
    Front Cell Neurosci; 2017; 11():31. PubMed ID: 28261062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered thymidine metabolism due to defects of thymidine phosphorylase.
    Spinazzola A; Marti R; Nishino I; Andreu AL; Naini A; Tadesse S; Pela I; Zammarchi E; Donati MA; Oliver JA; Hirano M
    J Biol Chem; 2002 Feb; 277(6):4128-33. PubMed ID: 11733540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythrocyte Encapsulated Thymidine Phosphorylase for the Treatment of Patients with Mitochondrial Neurogastrointestinal Encephalomyopathy: Study Protocol for a Multi-Centre, Multiple Dose, Open Label Trial.
    Bax BE; Levene M; Bain MD; Fairbanks LD; Filosto M; Kalkan Uçar S; Klopstock T; Kornblum C; Mandel H; Rahman S; Roubertie A; Scarpelli M; Sedgwick PM; Baru M; Sellos-Moura M; Price J; Horn P; Nirmalananthan N
    J Clin Med; 2019 Jul; 8(8):. PubMed ID: 31344955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Restoration of Thymidine Phosphorylase Function and Nucleoside Homeostasis Using Hematopoietic Gene Therapy in a Murine Model of Mitochondrial Neurogastrointestinal Encephalomyopathy.
    Torres-Torronteras J; Cabrera-Pérez R; Barba I; Costa C; de Luna N; Andreu AL; Barquinero J; Hirano M; Cámara Y; Martí R
    Hum Gene Ther; 2016 Sep; 27(9):656-67. PubMed ID: 27004974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymidine phosphorylase gene mutations in patients with mitochondrial neurogastrointestinal encephalomyopathy syndrome.
    Slama A; Lacroix C; Plante-Bordeneuve V; Lombès A; Conti M; Reimund JM; Auxenfants E; Crenn P; Laforêt P; Joannard A; Seguy D; Pillant H; Joly P; Haut S; Messing B; Said G; Legrand A; Guiochon-Mantel A
    Mol Genet Metab; 2005 Apr; 84(4):326-31. PubMed ID: 15781193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematopoietic gene therapy restores thymidine phosphorylase activity in a cell culture and a murine model of MNGIE.
    Torres-Torronteras J; Gómez A; Eixarch H; Palenzuela L; Pizzorno G; Hirano M; Andreu AL; Barquinero J; Martí R
    Gene Ther; 2011 Aug; 18(8):795-806. PubMed ID: 21451581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical toxicity evaluation of erythrocyte-encapsulated thymidine phosphorylase in BALB/c mice and beagle dogs: an enzyme-replacement therapy for mitochondrial neurogastrointestinal encephalomyopathy.
    Levene M; Coleman DG; Kilpatrick HC; Fairbanks LD; Gangadharan B; Gasson C; Bax BE
    Toxicol Sci; 2013 Jan; 131(1):311-24. PubMed ID: 22977166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Definitive diagnosis of mitochondrial neurogastrointestinal encephalomyopathy by biochemical assays.
    Martí R; Spinazzola A; Tadesse S; Nishino I; Nishigaki Y; Hirano M
    Clin Chem; 2004 Jan; 50(1):120-4. PubMed ID: 14633909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of thymidine phosphorylase activity disrupts adipocyte differentiation and induces insulin-resistant lipoatrophic diabetes.
    Gautheron J; Lima L; Akinci B; Zammouri J; Auclair M; Ucar SK; Ozen S; Altay C; Bax BE; Nemazanyy I; Lenoir V; Prip-Buus C; Acquaviva-Bourdain C; Lascols O; Fève B; Vigouroux C; Noel E; Jéru I
    BMC Med; 2022 Mar; 20(1):95. PubMed ID: 35341481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymidine phosphorylase gene mutation is not a primary cause of mitochondrial neurogastrointestinal encephalomyopathy (MNGIE).
    Kumagai Y; Sugiura Y; Sugeno H; Takebayashi Y; Takenoshita S; Yamamoto T
    Intern Med; 2006; 45(7):443-6. PubMed ID: 16679698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MNGIE with lack of skeletal muscle involvement and a novel TP splice site mutation.
    Szigeti K; Wong LJ; Perng CL; Saifi GM; Eldin K; Adesina AM; Cass DL; Hirano M; Lupski JR; Scaglia F
    J Med Genet; 2004 Feb; 41(2):125-9. PubMed ID: 14757860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late-onset MNGIE due to partial loss of thymidine phosphorylase activity.
    Martí R; Verschuuren JJ; Buchman A; Hirano I; Tadesse S; van Kuilenburg AB; van Gennip AH; Poorthuis BJ; Hirano M
    Ann Neurol; 2005 Oct; 58(4):649-52. PubMed ID: 16178026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of Plasma and Urine Thymidine and 2'-Deoxyuridine by LC-MS/MS for the Pharmacodynamic Evaluation of Erythrocyte Encapsulated Thymidine Phosphorylase in Patients with Mitochondrial Neurogastrointestinal Encephalomyopathy.
    Kipper K; Hecht M; Antunes NJ; Fairbanks LD; Levene M; Kalkan Uçar S; Schaefer A; Blakely EL; Bax BE
    J Clin Med; 2020 Mar; 9(3):. PubMed ID: 32183169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymidine phosphorylase deficiency causes MNGIE: an autosomal recessive mitochondrial disorder.
    Hirano M; Martí R; Spinazzola A; Nishino I; Nishigaki Y
    Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1217-25. PubMed ID: 15571233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymidine phosphorylase is both a therapeutic and a suicide gene in a murine model of mitochondrial neurogastrointestinal encephalomyopathy.
    López-Estévez S; Ferrer G; Torres-Torronteras J; Mansilla MJ; Casacuberta-Serra S; Martorell L; Hirano M; Martí R; Barquinero J
    Gene Ther; 2014 Jul; 21(7):673-81. PubMed ID: 24807807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial neurogastrointestinal encephalomyopathy and thymidine metabolism: results and hypotheses.
    Marti R; Spinazzola A; Nishino I; Andreu AL; Naini A; Tadesse S; Oliver JA; Hirano M
    Mitochondrion; 2002 Nov; 2(1-2):143-7. PubMed ID: 16120316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a disease of two genomes.
    Hirano M; Nishigaki Y; Martí R
    Neurologist; 2004 Jan; 10(1):8-17. PubMed ID: 14720311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted deletion of both thymidine phosphorylase and uridine phosphorylase and consequent disorders in mice.
    Haraguchi M; Tsujimoto H; Fukushima M; Higuchi I; Kuribayashi H; Utsumi H; Nakayama A; Hashizume Y; Hirato J; Yoshida H; Hara H; Hamano S; Kawaguchi H; Furukawa T; Miyazono K; Ishikawa F; Toyoshima H; Kaname T; Komatsu M; Chen ZS; Gotanda T; Tachiwada T; Sumizawa T; Miyadera K; Osame M; Yoshida H; Noda T; Yamada Y; Akiyama S
    Mol Cell Biol; 2002 Jul; 22(14):5212-21. PubMed ID: 12077348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.